# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001827506-25-000086
Filing Date
2025-06-09
Accepted
2025-06-09 08:11:12
Documents
60
Period of Report
2025-06-09
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | trml-20250609.htm iXBRL | 8-K | 28378
2 | EX-99.1 | tourmalinecorporateoverv.htm | EX-99.1 | 67707
6 |  | tourmalinecorporateoverv001.jpg | GRAPHIC | 40018
7 |  | tourmalinecorporateoverv002.jpg | GRAPHIC | 287174
8 |  | tourmalinecorporateoverv003.jpg | GRAPHIC | 86603
9 |  | tourmalinecorporateoverv004.jpg | GRAPHIC | 120085
10 |  | tourmalinecorporateoverv005.jpg | GRAPHIC | 118400
11 |  | tourmalinecorporateoverv006.jpg | GRAPHIC | 146607
12 |  | tourmalinecorporateoverv007.jpg | GRAPHIC | 102190
13 |  | tourmalinecorporateoverv008.jpg | GRAPHIC | 31100
14 |  | tourmalinecorporateoverv009.jpg | GRAPHIC | 127112
15 |  | tourmalinecorporateoverv010.jpg | GRAPHIC | 156101
16 |  | tourmalinecorporateoverv011.jpg | GRAPHIC | 134941
17 |  | tourmalinecorporateoverv012.jpg | GRAPHIC | 135941
18 |  | tourmalinecorporateoverv013.jpg | GRAPHIC | 156765
19 |  | tourmalinecorporateoverv014.jpg | GRAPHIC | 115804
20 |  | tourmalinecorporateoverv015.jpg | GRAPHIC | 155011
21 |  | tourmalinecorporateoverv016.jpg | GRAPHIC | 146203
22 |  | tourmalinecorporateoverv017.jpg | GRAPHIC | 154090
23 |  | tourmalinecorporateoverv018.jpg | GRAPHIC | 158353
24 |  | tourmalinecorporateoverv019.jpg | GRAPHIC | 134180
25 |  | tourmalinecorporateoverv020.jpg | GRAPHIC | 124975
26 |  | tourmalinecorporateoverv021.jpg | GRAPHIC | 127747
27 |  | tourmalinecorporateoverv022.jpg | GRAPHIC | 156482
28 |  | tourmalinecorporateoverv023.jpg | GRAPHIC | 141081
29 |  | tourmalinecorporateoverv024.jpg | GRAPHIC | 131494
30 |  | tourmalinecorporateoverv025.jpg | GRAPHIC | 121747
31 |  | tourmalinecorporateoverv026.jpg | GRAPHIC | 155057
32 |  | tourmalinecorporateoverv027.jpg | GRAPHIC | 157685
33 |  | tourmalinecorporateoverv028.jpg | GRAPHIC | 141170
34 |  | tourmalinecorporateoverv029.jpg | GRAPHIC | 134089
35 |  | tourmalinecorporateoverv030.jpg | GRAPHIC | 160660
36 |  | tourmalinecorporateoverv031.jpg | GRAPHIC | 148957
37 |  | tourmalinecorporateoverv032.jpg | GRAPHIC | 161716
38 |  | tourmalinecorporateoverv033.jpg | GRAPHIC | 147887
39 |  | tourmalinecorporateoverv034.jpg | GRAPHIC | 150461
40 |  | tourmalinecorporateoverv035.jpg | GRAPHIC | 26792
41 |  | tourmalinecorporateoverv036.jpg | GRAPHIC | 174579
42 |  | tourmalinecorporateoverv037.jpg | GRAPHIC | 155270
43 |  | tourmalinecorporateoverv038.jpg | GRAPHIC | 130107
44 |  | tourmalinecorporateoverv039.jpg | GRAPHIC | 136767
45 |  | tourmalinecorporateoverv040.jpg | GRAPHIC | 194864
46 |  | tourmalinecorporateoverv041.jpg | GRAPHIC | 155920
47 |  | tourmalinecorporateoverv042.jpg | GRAPHIC | 132122
48 |  | tourmalinecorporateoverv043.jpg | GRAPHIC | 116824
49 |  | tourmalinecorporateoverv044.jpg | GRAPHIC | 22115
50 |  | tourmalinecorporateoverv045.jpg | GRAPHIC | 130920
51 |  | tourmalinecorporateoverv046.jpg | GRAPHIC | 106266
52 |  | tourmalinecorporateoverv047.jpg | GRAPHIC | 29610
| Complete submission text file | 0001827506-25-000086.txt |  | 8762656

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | trml-20250609.xsd | EX-101.SCH | 1800
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | trml-20250609_lab.xml | EX-101.LAB | 23449
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | trml-20250609_pre.xml | EX-101.PRE | 13593
62 | EXTRACTED XBRL INSTANCE DOCUMENT | trml-20250609_htm.xml | XML | 2915

Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40384 | Film No.: 251032878
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)